iVAC 2L is PulseCath’s percutaneous pulsatile mechanical circulatory support device, designed to provide temporary left ventricular support in patients with impaired left ventricular function. The iVAC 2L provides up to 2.0 L/min of circulatory support and is intended for left ventricular mechanical circulatory support for up to 24 hours. The iVAC 2L works in combination with a conventional intra-aortic balloon pump (IABP) driver and provides pulsatile support synchronized with the patient’s cardiac cycle. Patient groups that may benefit from iVAC 2L include patients undergoing high-risk percutaneous coronary intervention (HR-PCI), as well as patients with acute myocardial infarction, cardiogenic shock, and those undergoing high-risk ablation and mapping procedures. Learn more about iVAC 2L and PulseCath at www.pulsecath.com.
Looking for a particular PulseCath BV employee's phone or email?
The PulseCath BV annual revenue was $2 million in 2026.
Oren Malchin is the CEO of PulseCath BV.
9 people are employed at PulseCath BV.
PulseCath BV is based in Arnhem, Gelderland.
The NAICS codes for PulseCath BV are [33, 339].
The SIC codes for PulseCath BV are [384, 38].